CN102988650A - Medicament for treating chronic nephritis and preparation method of medicament - Google Patents
Medicament for treating chronic nephritis and preparation method of medicament Download PDFInfo
- Publication number
- CN102988650A CN102988650A CN 201210469205 CN201210469205A CN102988650A CN 102988650 A CN102988650 A CN 102988650A CN 201210469205 CN201210469205 CN 201210469205 CN 201210469205 A CN201210469205 A CN 201210469205A CN 102988650 A CN102988650 A CN 102988650A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicament
- chronic nephritis
- roots
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating chronic nephritis. The medicament is prepared from the following raw materials in parts by weight: 20-200 parts of pilose asiabell roots, 20-50 parts of heterophylly falsestarwort roots, 10-50 parts of largehead atractylodes rhizomes, 15-150 parts of Indian buead, 30-100 parts of cooked rehmannia, 12-100 parts of dogwood fruits, 20-150 parts of south dodder seeds, 15-100 parts of peach seeds, 10-100 parts of safflower, 15-100 parts of danshen roots, 15-100 parts of weeping forsythiae capsule, 15-100 parts of kudzuvine roots, 10-200 parts of golden thread, 15-150 parts of pinellia tubers and 15-100 parts of liquoric roots. The invention also discloses a method for preparing a Chinese medicinal composition for treating the chronic nephritis. According to folk traditional formula, the medicament is prepared by meticulously researching in combination with the theraputic principle of strengthening the body resistance and fostering the root and activating blood and dispersing blood stasis in traditional Chinese medical science. The chronic nephritis is treated by using a combined principle of strengthening the body resistance to eliminate pathogenic factors and using methods of promoting blood circulation to remove blood stasis, strengthening the kidney and tonifying the spleen and clearing away the heat to resolve turbidity by dieresis, so that the advantages of good effect, quick response and the like are realized.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of medicine for the treatment of chronic nephritis.
Background technology
Chronic glomerulonephritis can betide any age, but take green grass or young crops, middle-aged male as main.Mode of onset and clinical manifestation are various.Most insidious onsets, slowly take hematuria, albuminuria, hypertension, edema as its basic clinical, can have in various degree renal hypofunction, protracted inflammation, repeatedly, gradual chronic renal failure, the uremia that namely it has often been said of developing into.At present at the field of Chinese medicines for the treatment of chronic nephritis, have DeGrain, the slow shortcoming that takes effect causes state of an illness development to become renal failure and then develops into uremia.
Summary of the invention
Goal of the invention: in order to overcome the deficiencies in the prior art, first technical problem that the present invention will solve provides a kind of medicine for the treatment of chronic nephritis, it can solve other Chinese medicines DeGrain and the slow problem that takes effect in treatment, and obtains instant effect, effective advantage.Another technical problem that the present invention will solve provides a kind of preparation method for the treatment of the Chinese medicine composition of rheumatoid arthritis.
Technical scheme: in order to solve above-mentioned first technical problem, the technical solution adopted in the present invention is:
A kind of medicine for the treatment of chronic nephritis, it is the medicament that the raw material by the following weight proportioning is prepared into:
A kind of medicine for the treatment of chronic nephritis is characterized in that: it is the medicament that the raw material by the following weight proportioning is prepared into:
Radix Codonopsis 20-200 part, Radix Pseudostellariae 20-50 part, Rhizoma Atractylodis Macrocephalae 10-50 part, Poria 15-150 part, Radix Rehmanniae Preparata 30-100 part, Fructus Corni 12-100 part, Semen Cuscutae 20-150 part, Semen Persicae 15-100 part, Flos Carthami 10-100 part, Radix Salviae Miltiorrhizae 15-100 part, Fructus Forsythiae 15-100 part, Radix Puerariae 15-100 part, Rhizoma Coptidis 10-200 part, Rhizoma Pinelliae 15-150 part, Radix Glycyrrhizae 15-100 part.
Further, in order to reach better curative effect, the invention provides a kind of medicine for the treatment of chronic nephritis, the weight proportion of each raw material is: 25 parts of Radix Codonopsis, 30 parts of Radix Pseudostellariaes, 40 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts in Poria, 25 parts in Radix Rehmanniae Preparata, 22 parts of Fructus Corni, 30 parts of Semen Cuscutae, 30 parts in Semen Persicae, 20 parts on Flos Carthami, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Fructus Forsythiaes, 22 parts of Radix Puerariaes, 25 parts of Rhizoma Coptidis, 30 parts of the Rhizoma Pinelliaes, 30 parts in Radix Glycyrrhizae.
In order to solve above-mentioned second technical problem, the technical solution adopted in the present invention is:
(1) according to following parts by weight weighting raw materials: Radix Codonopsis 20-200 part, Radix Pseudostellariae 20-50 part, Rhizoma Atractylodis Macrocephalae 10-50 part, Poria 15-150 part, Radix Rehmanniae Preparata 30-100 part, Fructus Corni 12-100 part, Semen Cuscutae 20-150 part, Semen Persicae 15-100 part, Flos Carthami 10-100 part, Radix Salviae Miltiorrhizae 15-100 part, Fructus Forsythiae 15-100 part, Radix Puerariae 15-100 part, Rhizoma Coptidis 10-200 part, Rhizoma Pinelliae 15-150 part, Radix Glycyrrhizae 15-100 part.
(2) the above-mentioned raw materials medicine is immersed in the water, soaked 20 ~ 35 minutes, with big fire that medicine is boiled after, little fire decocts twice, decocts 1 hour at every turn, and medicinal residues are filtered, and is used for the merging of twice filtrate oral.
Beneficial effect: the present invention is according to the folk tradition prescription, and the theory in conjunction with traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.The methods such as treatment is take strengthening vital QI to eliminate pathogenic factors and with as principle, and employing blood circulation promoting and blood stasis dispelling, kidney and spleen invigorating, clearing away heat-damp and promoting diuresisization are turbid have reached the advantages such as effective, instant effect.
The specific embodiment
According to following embodiment, the present invention may be better understood.Yet, those skilled in the art will readily understand, the described concrete technology path of embodiment and result thereof only are used for explanation the present invention, and should also can not limit the present invention described in detail in claims.
Get following prescription (weight is unit by gram):
25 parts of Radix Codonopsis, 30 parts of Radix Pseudostellariaes, 40 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts in Poria, 25 parts in Radix Rehmanniae Preparata, 22 parts of Fructus Corni, 30 parts of Semen Cuscutae, 30 parts in Semen Persicae, 20 parts on Flos Carthami, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Fructus Forsythiaes, 22 parts of Radix Puerariaes, 25 parts of Rhizoma Coptidis, 30 parts of the Rhizoma Pinelliaes, 30 parts in Radix Glycyrrhizae.
The above-mentioned raw materials medicine is immersed in the water, soaked 20 ~ 35 minutes, with big fire that medicine is boiled after, little fire decocts twice, decocts 1 hour at every turn, and medicinal residues are filtered, and is used for the merging of twice filtrate oral.
Further set forth beneficial effect of the present invention below by clinical trial.
Select 100 patients with chronic glomerulonephritis to carry out system's clinical observation according to conditions of patients, the patient is divided into test group and matched group at random, every group of 50 people, test group is treated according to the prescription in embodiment 1 or the experimental example 2; Matched group is taken commercially available western medicine;
Usage and dosage: be decocted in water for oral dose 2 times on the one.15 days is a course for the treatment of, totally 3 courses for the treatment of.
The curative effect of test group and matched group clinical trial is as shown in the table:
| Group | Case load | Produce effects | Effectively | Invalid | Total effective rate % |
| Test group | 50 | 18 | 28 | 4 | 92% |
| Matched group | 50 | 7 | 20 | 25 | 54% |
Test data in upper table statistics shows, take the patient of this medicine, what significant curative effect was arranged accounts for 36%, accounts for 14% and matched group has a significant curative effect, and hence one can see that, and test group has the matched group that is far longer than of significant curative effect, and the value of clinical expansion is arranged.
Claims (3)
1. medicine for the treatment of chronic nephritis is characterized in that: it is the medicament that the raw material by the following weight proportioning is prepared into: Radix Codonopsis 20-200 part, Radix Pseudostellariae 20-50 part, Rhizoma Atractylodis Macrocephalae 10-50 part, Poria 15-150 part, Radix Rehmanniae Preparata 30-100 part, Fructus Corni 12-100 part, Semen Cuscutae 20-150 part, Semen Persicae 15-100 part, Flos Carthami 10-100 part, Radix Salviae Miltiorrhizae 15-100 part, Fructus Forsythiae 15-100 part, Radix Puerariae 15-100 part, Rhizoma Coptidis 10-200 part, Rhizoma Pinelliae 15-150 part, Radix Glycyrrhizae 15-100 part.
2. a kind of medicine for the treatment of chronic nephritis according to claim 1, it is characterized in that: the weight proportion of described each raw material is: 25 parts of Radix Codonopsis, 30 parts of Radix Pseudostellariaes, 40 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts in Poria, 25 parts in Radix Rehmanniae Preparata, 22 parts of Fructus Corni, 30 parts of Semen Cuscutae, 30 parts in Semen Persicae, 20 parts on Flos Carthami, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Fructus Forsythiaes, 22 parts of Radix Puerariaes, 25 parts of Rhizoma Coptidis, 30 parts of the Rhizoma Pinelliaes, 30 parts in Radix Glycyrrhizae.
3. claim 1 or 2 described a kind of preparation methoies for the treatment of the Chinese medicine composition of rheumatoid arthritis, it is characterized in that: weighting raw materials by weight ratio, crude drug is immersed in the water, soaked 20 ~ 35 minutes, after with big fire that medicine is boiled, little fire decocts twice, decocts 1 hour at every turn, medicinal residues are filtered, be used for the merging of twice filtrate oral.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210469205 CN102988650A (en) | 2012-11-20 | 2012-11-20 | Medicament for treating chronic nephritis and preparation method of medicament |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210469205 CN102988650A (en) | 2012-11-20 | 2012-11-20 | Medicament for treating chronic nephritis and preparation method of medicament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102988650A true CN102988650A (en) | 2013-03-27 |
Family
ID=47918080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210469205 Pending CN102988650A (en) | 2012-11-20 | 2012-11-20 | Medicament for treating chronic nephritis and preparation method of medicament |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102988650A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106265918A (en) * | 2016-09-20 | 2017-01-04 | 陈亚平 | A kind of Chinese medicine treating chronic nephritis and preparation method thereof |
| CN107625922A (en) * | 2017-11-24 | 2018-01-26 | 管章亮 | A kind of medicine for treating chronic nephritis and preparation method thereof |
| CN111643628A (en) * | 2020-06-24 | 2020-09-11 | 博奥生物集团有限公司 | Traditional Chinese medicine for regulating inflammation and/or fibrosis related signal pathway and application thereof |
-
2012
- 2012-11-20 CN CN 201210469205 patent/CN102988650A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106265918A (en) * | 2016-09-20 | 2017-01-04 | 陈亚平 | A kind of Chinese medicine treating chronic nephritis and preparation method thereof |
| CN107625922A (en) * | 2017-11-24 | 2018-01-26 | 管章亮 | A kind of medicine for treating chronic nephritis and preparation method thereof |
| CN111643628A (en) * | 2020-06-24 | 2020-09-11 | 博奥生物集团有限公司 | Traditional Chinese medicine for regulating inflammation and/or fibrosis related signal pathway and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN103933468A (en) | Traditional Chinese medicine for treating acute pancreatitis | |
| CN103638370A (en) | Traditional Chinese medicine for treating dental ulcer | |
| CN103127422B (en) | Medicament for treating ulcerative colitis | |
| CN103041203A (en) | Traditional Chinese medicine formula for treating chronic pyelonephritis | |
| CN102727779A (en) | Pharmaceutical composition for treating ovarian cysts and preparation method thereof | |
| CN102988650A (en) | Medicament for treating chronic nephritis and preparation method of medicament | |
| CN101897789A (en) | Chinese medicinal preparation for treating diarrhea | |
| CN103623385B (en) | A kind of Chinese medicine for the treatment of oral ulcer | |
| CN102125621B (en) | Traditional Chinese medicine preparation for treating senile constipation | |
| CN103893457A (en) | Traditional Chinese medicine for treating ulcerative colitis | |
| CN101085088A (en) | Traditional Chinese medicine formula for treating prostatic hyperplasia | |
| CN103845620A (en) | Traditional Chinese medicine for treating raynaud disease | |
| CN103800840A (en) | Oral traditional Chinese medicine solution for treating cervical spondylosis | |
| CN103479947A (en) | Preparation method of medicine for preventing and treating constipation | |
| CN103100035A (en) | Traditional Chinese medicine (TCM) decoction for treating globus hysteriocus | |
| CN101502597B (en) | Medicament for treating stomachache and preparation method thereof | |
| CN101658652A (en) | Chinese medicinal preparation for treating chronic appendicitis | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN104667243A (en) | Traditional Chinese medicament for treating ulcerative colitis | |
| CN103816343A (en) | Traditional Chinese medicine composition for treating head ring of old people | |
| CN103417857B (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN101810745B (en) | Plaster for treating hyperplasia of mammary glands | |
| CN102846998A (en) | A Chinese medicinal formulation for treating chronic enteritis (due to diarrhea induced by spleen deficiency) | |
| CN102309648A (en) | Traditional Chinese medicine prescription for treating postpartum retention of lochia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130327 |